1.
EBVaGC的临床病理特征
The clinicopathological features of EBVaGC
| Variables | EBVaGC (n=163) | EBVnGC (n=3 078) | Statistics value | P value |
| EBVaGC, Epstein-Barr virus associated gastric cancer; EBVnGC, Epstein-Barr virus non-associated gastric cancer; WHO, World Health Organization; LELC, lymphoepithelioma-like carcinoma; GC, gastric cancer. | ||||
| Gender, n | χ2=10.783 | 0.001 | ||
| Male | 137 | 2 226 | ||
| Female | 26 | 852 | ||
| Age/years, x±s | 55.9±10.8 | 59.7±11.1 | t=16.959 | <0.001 |
| WHO classification, n | χ2=399.138 | <0.001 | ||
| Adenocarcinoma | 142 | 3 078 | ||
| LELC | 21 | 0 | ||
| Lauren type, n | χ2=16.547 | <0.001 | ||
| Intestinal-type | 50 | 1 431 | ||
| Diffuse-type | 50 | 798 | ||
| Mixed-type | 63 | 849 | ||
| Differentiation, n | χ2=35.086 | <0.001 | ||
| Poorly | 112 | 1 403 | ||
| Moderately | 51 | 1 581 | ||
| Well | 0 | 94 | ||
| Location, n | χ2=0.620 | 0.431 | ||
| Cardia | 34 | 814 | ||
| Non-cardia | 129 | 2 264 | ||
| TNM stage, n | χ2=6.797 | 0.079 | ||
| Ⅰ | 44 | 615 | ||
| Ⅱ | 32 | 688 | ||
| Ⅲ | 71 | 1 546 | ||
| Ⅳ | 16 | 229 | ||
| T, n | χ2=4.679 | 0.197 | ||
| T1 | 31 | 499 | ||
| T2 | 25 | 416 | ||
| T3 | 62 | 1 437 | ||
| T4 | 45 | 726 | ||
| N, n | χ2=4.772 | 0.029 | ||
| Positive | 92 | 1 996 | ||
| Negative | 71 | 1 082 | ||
| M, n | χ2=1.251 | 0.263 | ||
| Positive | 16 | 229 | ||
| Negative | 147 | 2 849 | ||
| Vascular invasion, n | χ2=7.775 | 0.005 | ||
| Positive | 62 | 1 586 | ||
| Negative | 91 | 1 460 | ||
| Remnant GC or not, n | χ2=8.204 | 0.004 | ||
| Yes | 7 | 44 | ||
| No | 156 | 3 034 | ||